DK0581904T3 - Fremgangsmåde til inhibering af fibrose - Google Patents

Fremgangsmåde til inhibering af fibrose

Info

Publication number
DK0581904T3
DK0581904T3 DK92917284.9T DK92917284T DK0581904T3 DK 0581904 T3 DK0581904 T3 DK 0581904T3 DK 92917284 T DK92917284 T DK 92917284T DK 0581904 T3 DK0581904 T3 DK 0581904T3
Authority
DK
Denmark
Prior art keywords
formula
fibrosis
alkyl
hydrogen
compound
Prior art date
Application number
DK92917284.9T
Other languages
Danish (da)
English (en)
Inventor
Sheldon R Pinnell
Saood Murad
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Application granted granted Critical
Publication of DK0581904T3 publication Critical patent/DK0581904T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK92917284.9T 1991-04-01 1992-03-31 Fremgangsmåde til inhibering af fibrose DK0581904T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67847291A 1991-04-01 1991-04-01

Publications (1)

Publication Number Publication Date
DK0581904T3 true DK0581904T3 (da) 1997-12-29

Family

ID=24722926

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92917284.9T DK0581904T3 (da) 1991-04-01 1992-03-31 Fremgangsmåde til inhibering af fibrose

Country Status (11)

Country Link
US (2) US5374660A (de)
EP (1) EP0581904B1 (de)
JP (1) JPH06506471A (de)
AT (1) ATE153500T1 (de)
AU (1) AU652644B2 (de)
CA (1) CA2107371A1 (de)
DE (1) DE69220050T2 (de)
DK (1) DK0581904T3 (de)
ES (1) ES2104938T3 (de)
GR (1) GR3024548T3 (de)
WO (1) WO1992017065A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE153500T1 (de) * 1991-04-01 1997-06-15 Univ Duke Verfahren zur inhibierung der fibrose
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
US6117445A (en) * 1998-01-28 2000-09-12 Link Technology Inc. Methods for the prevention and treatment of fibrosis and sclerosis
EP3175855B1 (de) 2004-03-12 2020-07-15 Intercept Pharmaceuticals, Inc. Behandlung von fibrose mit fxr-liganden
AT509045B1 (de) 2010-01-29 2011-06-15 Planta Naturstoffe Vertriebsges M B H Verbindungen zur behandlung von asthma bronchiale
LT2953948T (lt) 2013-02-07 2018-01-10 Scifluor Life Sciences, Inc Fluorinti integrino antagonistai
WO2016134223A2 (en) 2015-02-19 2016-08-25 Scifluor Life Sciences, Inc. Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
CN108040467A (zh) 2015-04-30 2018-05-15 赛弗卢尔生命科学公司 四氢萘啶基丙酸衍生物及其用途
US10118929B2 (en) 2016-04-27 2018-11-06 Scifluor Life Sciences, Inc. Nonanoic and decanoic acid derivatives and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB828344A (en) * 1957-01-30 1960-02-17 Ici Ltd Veterinary compositions containing acid hydrazides
JPS5119135A (en) * 1974-08-05 1976-02-16 Itsuo Takeshita Kohakusenzaino seiho
US4321273A (en) * 1978-03-01 1982-03-23 Ryuichi Sato Germanium-containing organic polymer and its use in the treatment of pulmonary fibrosis
US4382941A (en) * 1980-11-26 1983-05-10 Sicardi Susana M Bishydrazide quaternary salts and pharmaceutical compositions thereof
HU207051B (en) * 1987-12-30 1993-03-01 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-chloro-3-sulfamoylbenzoic acid hydrazides and pharmaceutical compositions comprising such compounds
ATE153500T1 (de) * 1991-04-01 1997-06-15 Univ Duke Verfahren zur inhibierung der fibrose

Also Published As

Publication number Publication date
JPH06506471A (ja) 1994-07-21
WO1992017065A3 (en) 1992-11-26
EP0581904A1 (de) 1994-02-09
EP0581904B1 (de) 1997-05-28
EP0581904A4 (en) 1994-05-25
ES2104938T3 (es) 1997-10-16
DE69220050D1 (de) 1997-07-03
US5571846A (en) 1996-11-05
WO1992017065A2 (en) 1992-10-15
US5374660A (en) 1994-12-20
AU1876392A (en) 1992-11-02
ATE153500T1 (de) 1997-06-15
AU652644B2 (en) 1994-09-01
CA2107371A1 (en) 1992-10-02
DE69220050T2 (de) 1998-01-22
GR3024548T3 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
TW255881B (de)
ES8609251A1 (es) Un procedimiento para preparar un compuesto de n-aril-n- -(4-piperidinil)-alcoxialquilamida
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
KR890005124A (ko) 세펨 화합물 및 이의 제조방법
ES8701228A1 (es) Un metodo para producir una propioxantina
DK0581904T3 (da) Fremgangsmåde til inhibering af fibrose
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
IL108970A0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
ATE161178T1 (de) Pyrazolpyridine für die behandlung der anämie
NO923413D0 (no) Terapeutiske benzazepin-forbindelser
ES8500899A1 (es) Procedimiento para preparar derivados de amidas de los acidos mercaptoacetico y 3-mercaptopropionico
NO950177D0 (no) Farmakologisk aktive erivater
ZA916977B (en) Pharmaceutical compositions for use in treating aids
DK549085A (da) 3-aminopropoxyphenylderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater, som indeholder disse derivater